Unknown

Dataset Information

0

Characterization of hepatitis C Virus genotype 3a hypervariable region 1 in patients achieved rapid virological response to alpha interferon and ribavirin combination therapy.


ABSTRACT: BACKGROUND: Hepatitis C virus roots a chronic liver disease. Currently approved treatment strategy includes administration of alpha interferon and ribavirin combined therapy for 24-48 weeks. One of the predictor of sustained virological response is an early virological response to treatment characterized as rapid response. Hyper variable region 1 (HVR1) of E2 protein is responsible for viral entry and acts as a target for neutralizing antibodies. Any mutation in this region would effect virus interaction with target cell and viral persistence. METHODS: Thirty one clones of six pre-treatment samples subjected to combination therapy were investigated. Three of the patients were rapid responders (R1, R2 and R3) and two were breakthrough responders (BT1 and BT2). Envelope 2 gene was amplified, cloned and sequenced. Amino acid substitution, frequency, composition and antigenic properties of HVR 1 of E2 protein were studied. RESULTS: In both rapid responders (R.R) (14 amino acid sites) and breakthrough responders (BT.R) (13 amino acid sites) half of the amino acid sites were either conserved or resistant to any physiochemical change due to amino acid substitution. It also indicated that average composition of hydrophilic and basic amino acids were comparatively lower in rapid responders than other samples affecting probable interaction of virus with target cells. A central non antigenic region was constant among the breakthrough responders but differed in length significantly among rapid responders reflecting the adaptive nature of HVR1 to the immune response. CONCLUSIONS: We observed that although HVR1is quite variable region in HCV 3a patients responding differently to treatment it still maintains its physiochemical properties for its proper functioning and viability.

SUBMITTER: Akram M 

PROVIDER: S-EPMC3117844 | biostudies-literature | 2011

REPOSITORIES: biostudies-literature

altmetric image

Publications

Characterization of hepatitis C Virus genotype 3a hypervariable region 1 in patients achieved rapid virological response to alpha interferon and ribavirin combination therapy.

Akram Madiha M   Idrees Muhammad M   Hussain Abrar A   Afzal Samia S   Ilyas Muhammad M   Zafar Shamail S   Aftab Mahwish M   Badar Sadaf S   Khubaib Bushra B  

Virology journal 20110523


<h4>Background</h4>Hepatitis C virus roots a chronic liver disease. Currently approved treatment strategy includes administration of alpha interferon and ribavirin combined therapy for 24-48 weeks. One of the predictor of sustained virological response is an early virological response to treatment characterized as rapid response. Hyper variable region 1 (HVR1) of E2 protein is responsible for viral entry and acts as a target for neutralizing antibodies. Any mutation in this region would effect v  ...[more]

Similar Datasets

| S-EPMC4146993 | biostudies-literature
| S-EPMC4386819 | biostudies-literature
| S-EPMC4960680 | biostudies-literature
| S-EPMC4385537 | biostudies-literature
| S-EPMC5397824 | biostudies-literature
| S-EPMC3024597 | biostudies-literature
| S-EPMC4330713 | biostudies-literature
| S-EPMC6731259 | biostudies-literature
| S-EPMC8137398 | biostudies-literature
| S-EPMC109659 | biostudies-literature